Search for: "Smith v. Merck"
Results 21 - 40
of 87
Sort by Relevance
|
Sort by Date
25 Jan 2017, 10:48 pm
Researching the answer In KCI v Smith & Nephew [2010] EWHC 1487 (Pat), Arnold J held that information that would be acquired by the skilled person as a matter of routine can, in addition to CGK, be taken into account in considering inventive step. [read post]
4 May 2016, 12:00 am
Smith, 261 F.2d 162 (3d Cir. 1958) and E.I. du Pont de Nemours & Co. v. [read post]
23 Dec 2015, 7:30 pm
Such was the story in Actavis v Lilly. [read post]
16 Aug 2015, 9:33 am
THE E. [read post]
13 Aug 2015, 10:56 am
Today we have a guest post (her second - she's a glutton for punishment) from fellow Reed Smith associate Danielle Devens. [read post]
25 Jun 2015, 5:00 am
Merck & Co., 948 A.2d 587 (N.J. 2008) (blogged here)). [read post]
25 Apr 2015, 11:03 am
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
7 Nov 2014, 5:52 am
Ellis v. [read post]
14 Oct 2014, 8:40 am
Thus, the court in an unpublished opinion denied without prejudice the pharmaceutical giant’s motion to dismiss and/or strike the claims (Smith v Merck & Co, Inc, October 8, 2014, Pisano, J). [read post]
6 Mar 2014, 12:41 pm
Glaxo Smith Kline Healthcare, 2006 WL 952032 (N.D. [read post]
5 Mar 2014, 2:46 pm
Supreme Court – constitutionality/remittitur of punitive damages in bifurcated action· Smith v. [read post]
6 Dec 2013, 11:55 am
A. [read post]
5 Dec 2013, 8:07 pm
A. [read post]
19 Sep 2013, 9:53 am
The following post is exclusively the work of the Reed Smith side of the blog.Sometimes the smallest, least significant type of lawsuit can illustrate cracks in the edifice of the largest, most consequential litigation. [read post]
5 Jul 2013, 5:00 am
” Perez v. [read post]
5 Jun 2013, 5:29 am
Wheelahan v. [read post]
23 Jan 2013, 2:03 pm
See Tamkin v. [read post]
23 Jan 2013, 2:03 pm
See Tamkin v. [read post]
13 Sep 2012, 4:26 pm
Louisiana Wholesale Drug Co., No. 12-245, and Upsher-Smith Laboratories, Inc. v. [read post]
29 Aug 2012, 10:09 pm
(“Merck”) (formerly Schering-Plough Corporation) restricted competition in violation of the Sherman Act by settling patent infringement lawsuits against potential generic K-DUR entrants, including Upsher-Smith Laboratories (“Upsher-Smith”). [read post]
